Moderna COVID-19 vaccine poised for US greenlight after FDA advisory panel endorsement abc11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc11.com Daily Mail and Mail on Sunday newspapers.
FDA authorizes Moderna COVID-19 vaccine for emergency use
By Matthew Perrone and Lauran Neergaard
Published
FDA advisory committee votes to recommend emergency use of Moderna COVID-19 vaccine
A key advisory committee to the FDA on Thursday voted to recommend the approval of Moderna’s COVID-19 vaccine for emergency use, one of the final hurdles before FDA authorization.
WASHINGTON - The U.S. Food and Drug Administration authorized Moderna’s coronavirus vaccine for emergency use on Friday, the second vaccine to be approved by U.S. regulators to prevent severe COVID-19 illness.
FDA Commissioner Stephen M. Hahn, called the approval another crucial step in the fight against this global pandemic.
FDA plans to OK 2nd COVID-19 vaccine after panel endorsement mooresvilletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mooresvilletribune.com Daily Mail and Mail on Sunday newspapers.
Share
Source: AP Photo/Hans Pennink
A week after the FDA approved the Pfizer/BioNTech coronavirus vaccine for emergency use, the agency has granted the same approval for Moderna s vaccine. In clinical trials, Moderna s candidate was over 94 percent effective.
Today, FDA issued an emergency use authorization (EUA) for the second vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The emergency use authorization allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. https://t.co/w4BQVg0n2Gpic.twitter.com/cw5JwYqxsh U.S. FDA (@US FDA) December 19, 2020
On Thursday night, the Vaccines and Related Biological Products Advisory Committee voted 20-0 to recommend the vaccine be made available.
1 of 2 FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)
2 of 2 FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers